NCT00666705 - A Study To Evaluate An Interaction Between Maraviroc And Raltegravir In Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions

Healthy

Interventions

DRUG

Maraviroc

300 milligrams(mg) every 12 hours Days 6-11

DRUG

Maraviroc

Days 12-14: Raltegravir 400 milligrams(mg) every 12 hours, maraviroc 300 milligrams(mg) every 12 hours (AM doses only on Day 14)

DRUG

Raltegravir

Days 12-14: Raltegravir 400 milligrams(mg) every 12 hours, maraviroc 300 milligrams(mg) every 12 hours (AM doses only on Day 14)

DRUG

Raltegravir

400 milligrams(mg) every 12 hours Days 1-3 Followed by washout Days 4-5

Trial Locations (1)

Pfizer Investigational Site, New Haven